Results 71 to 80 of about 25,812 (159)

Human biomarker navigator

open access: yesiMeta, Volume 5, Issue 5, October 2026.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

Essential Thrombocythemia

open access: yes, 2002
peripheral smear of essential thrombocythemia (ET ...
Lawrence, Christine
core  

Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome

open access: yesAmerican Journal of Hematology, Volume 101, Issue 9, Page 2147-2156, September 2026.
ABSTRACT Acquired von Willebrand Syndrome (AVWS) is a rare bleeding disorder characterized by quantitative or qualitative defects of von Willebrand factor (VWF) in patients without a personal or family history of bleeding. It is frequently associated with systemic diseases, particularly lymphoproliferative disorders (LPDs) and myeloproliferative ...
Alessandro Ciavarella   +10 more
wiley   +1 more source

Acute myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor

open access: yes, 2004
Essential thrombocythemia (ET) rarely causes obstruction of coronary arteries or acute myocardial infarction. Treatment of acute myocardial infarction in patients with ET may be a problem due to the important role of platelets in the pathogenesis of ...
Özbay, G   +6 more
core   +1 more source

Walsh & Hoyt: Essential Thrombocythemia

open access: yes, 2005
Essential thrombocythemia (primary thrombocythemia, hemorrhagic thrombocythemia, idiopathic thrombocythemia) is a chronic myeloproliferative disorder in which the predominant laboratory feature is a persistent, striking thrombocytosis with elevation of ...
John Kerrison, MD
core  

The thrombopoietin receptor S264F mutant drives MPN with marrow fibrosis through a dual mechanism

open access: yes
HemaSphere, Volume 10, Issue 10, October 2026.
Charlotte Lees   +9 more
wiley   +1 more source

Plateletpheresis for treating essential thrombocythemia that developed during pregnancy: A case report

open access: yesTaiwanese Journal of Obstetrics & Gynecology
Objective: Essential thrombocythemia (ET), a life-threatening disease, is associated with increased risks of hemorrhagic and thromboembolic complications.
Naohisa Masuko   +12 more
doaj   +1 more source

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

open access: yesHaematologica, 2017
The myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia and myelofibrosis, are distinguished by their debilitating symptom profiles, life-threatening complications and profound impact on quality of life.
Holly L. Geyer   +51 more
doaj   +1 more source

Pseudo-acquired vWD in essential thrombocythemia: the role of platelets

open access: yes, 2014
Essential Thrombocythemia affects von Willebrand ...
Lancellotti, Stefano   +4 more
core  

Essential thrombocythemia and pregnancy: a report of six normal pregnancies in five untreated patients

open access: yes, 1994
To report our experience with essential thrombocythemia complicating pregnancy. METHODS: Over a 5-year period, we studied 21 women of reproductive age affected by essential thrombocythemia.
Barbone E   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy